Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -11.47% vs 22.25% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.00% vs 0.00% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -0.41% vs 71.40% in Mar 2024
Compare Balance Sheet Results of Dipna Pharmachem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
24.05
7.55
16.50
218.54%
Share Warrants & Outstandings
Total Reserve
14.45
22.42
-7.97
-35.55%
Shareholder's Funds
38.49
29.97
8.52
28.43%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.89
2.28
6.61
289.91%
Secured Loans
0.00
1.03
-1.03
-100.00%
Unsecured Loans
8.89
1.25
7.64
611.20%
Deferred Tax Assets / Liabilities
-0.00
-0.07
0.07
100.00%
Other Long Term Liabilities
0.00
0.03
-0.03
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
8.89
2.24
6.65
296.88%
Current Liabilities
Trade Payables
75.72
8.95
66.77
746.03%
Other Current Liabilities
0.94
41.72
-40.78
-97.75%
Short Term Borrowings
8.33
18.58
-10.25
-55.17%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
85.00
69.25
15.75
22.74%
Total Liabilities
132.38
101.46
30.92
30.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.13
4.25
-4.12
-96.94%
Less: Accumulated Depreciation
0.08
1.63
-1.55
-95.09%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.05
2.62
-2.57
-98.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
1.39
-1.39
-100.00%
Total Non-Current Assets
0.05
4.01
-3.96
-98.75%
Current Assets Loans & Advances
Current Investments
0.00
0.14
-0.14
-100.00%
Inventories
27.43
0.69
26.74
3,875.36%
Sundry Debtors
46.28
35.95
10.33
28.73%
Cash and Bank
0.43
0.67
-0.24
-35.82%
Other Current Assets
1.14
1.11
0.03
2.70%
Short Term Loans and Advances
57.05
58.90
-1.85
-3.14%
Total Current Assets
132.33
97.45
34.88
35.79%
Net Current Assets (Including Current Investments)
47.33
28.20
19.13
67.84%
Total Current Assets Excluding Current Investments
132.33
97.31
35.02
35.99%
Miscellaneous Expenses not written off
0.00
0.44
-0.44
-100.00%
Total Assets
132.38
101.46
30.92
30.48%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
17.22
20.86
-3.64
-17.45%
Book Value per share (adjusted)
16.01
39.72
-23.71
-59.69%
Annual - Borrowings
Borrowings 17.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.47% vs 22.25% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.00% vs 0.00% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 132.33 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.41% vs 71.40% in Mar 2024






